×
戻る Agenda
Session 10 Track 3: Real-World Case Studies in Oligonucleotide CMC Development and Commercialization
Session Chair(s)
Firoz Antia, PHD
Vice President, Oligonucleotide and Small Molecule CMC
Denali Therapeutics, United States
Session 10 Track 3: Real-World Case Studies in Oligonucleotide CMC Development and Commercialization